Diagnosis-group-specific transitional care program recommendations for 30-day rehospitalization reduction
From MaRDI portal
Publication:2247498
Recommendations
- A continuous-time Markov model for estimating readmission risk for hospital inpatients
- Modelling risk of readmission with phase-type distribution and transition models
- Evaluating readmission rates and discharge planning by analyzing the length-of-stay of patients
- Sequential multiple assignment randomized trial (SMART) with adaptive randomization for quality improvement in depression treatment program
- Estimating the optimal individualized treatment rule from a cost‐effectiveness perspective
Cites work
- scientific article; zbMATH DE number 3137858 (Why is no real title available?)
- scientific article; zbMATH DE number 845714 (Why is no real title available?)
- A general statistical framework for subgroup identification and comparative treatment scoring
- A robust method for estimating optimal treatment regimes
- Causal Inference Using Potential Outcomes
- Estimating individualized treatment rules using outcome weighted learning
- Estimating treatment effect heterogeneity in randomized program evaluation
- Estimation of Regression Coefficients When Some Regressors Are Not Always Observed
- Maximin projection learning for optimal treatment decision with heterogeneous individualized treatment effects
- Nearly unbiased variable selection under minimax concave penalty
- Performance guarantees for individualized treatment rules
- Regression modelling on stratified data with the Lasso
- Regularization and Variable Selection Via the Elastic Net
- Responder identification in clinical trials with censored data
- Statistics and Causal Inference
- Variable Selection via Nonconcave Penalized Likelihood and its Oracle Properties
This page was built for publication: Diagnosis-group-specific transitional care program recommendations for 30-day rehospitalization reduction
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2247498)